2000
DOI: 10.1038/sj.leu.2401702
|View full text |Cite
|
Sign up to set email alerts
|

Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

2000
2000
2013
2013

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(15 citation statements)
references
References 43 publications
1
14
0
Order By: Relevance
“…As shown in Figure 5a, b and c, Bcl-2 and Mcl-1 protein expression suffered a significant decrease after CD5 hypercross-linking in B-CLL cells from patient group A (Bcl-2 MFIR 26.9 ± 7.7 control vs 12.5 ± 6.6 in CD5 hypercross-linked, P Ͻ 0.01, Mcl-1 MFIR 27.7 ± 7.4 control vs 11.5 ± 5.4, P Ͻ 0.01), while Bax protein expression was significantly increased (MFIR 14.9 ± 10.3 con- trol vs 29.5 ± 6.5, P Ͻ 0.01). Because a functional inducible nitric oxide synthase displaying anti-apoptotic activity was demonstrated in B-CLL and hairy cell leukemia, [25][26][27] we also examined iNOS expression after CD5 hypercross-linking in eight group A and 11 group B patients, and found a significant decrease of its levels in the B-CLL cells of group A patients (MFIR 10.8 ± 3.4 control vs 5.1 ± 2.0, P Ͻ 0.01), as shown in Figure 5d. Nothing significant happened with the expression of these apoptosis-related proteins in the cells from the 11 group B patients tested.…”
Section: Modulation Of the Apoptosis-related Proteins After Cd5 Hypermentioning
confidence: 99%
“…As shown in Figure 5a, b and c, Bcl-2 and Mcl-1 protein expression suffered a significant decrease after CD5 hypercross-linking in B-CLL cells from patient group A (Bcl-2 MFIR 26.9 ± 7.7 control vs 12.5 ± 6.6 in CD5 hypercross-linked, P Ͻ 0.01, Mcl-1 MFIR 27.7 ± 7.4 control vs 11.5 ± 5.4, P Ͻ 0.01), while Bax protein expression was significantly increased (MFIR 14.9 ± 10.3 con- trol vs 29.5 ± 6.5, P Ͻ 0.01). Because a functional inducible nitric oxide synthase displaying anti-apoptotic activity was demonstrated in B-CLL and hairy cell leukemia, [25][26][27] we also examined iNOS expression after CD5 hypercross-linking in eight group A and 11 group B patients, and found a significant decrease of its levels in the B-CLL cells of group A patients (MFIR 10.8 ± 3.4 control vs 5.1 ± 2.0, P Ͻ 0.01), as shown in Figure 5d. Nothing significant happened with the expression of these apoptosis-related proteins in the cells from the 11 group B patients tested.…”
Section: Modulation Of the Apoptosis-related Proteins After Cd5 Hypermentioning
confidence: 99%
“…73 Similar results were reported for ESKOL cells and for tumoral cells of HCL patients and it was shown that NO released played an anti-apoptotic role. 74,75 iNOS expression was also detected in seven out of eight human T cell leukemia virus type-I (HTLV-I)-infected cell lines (ATL-derived lines and in vitro transformed lines). Four out of nine ATL (adult T cell leukemia) patients of different subtypes (chronic or acute) also showed iNOS expression and the latter was found in all subtypes of ATL.…”
Section: Anti-apoptotic Effects Of Nomentioning
confidence: 99%
“…The expression of functional NOS-II in different human cell types including leukemia cells 11,13,29,30 investigated the role of NO as a member of anti-leukemia tools of macrophages. 3,31 The present study indicates that BCR-ABL + myeloid leukemia cells remained sensitive to the anti-proliferation property of exogenous NO.…”
Section: Discussionmentioning
confidence: 99%